A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Conditions
Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Esophageal Squamous Cell Carcinoma · Cervical Squamous Cell Carcinoma · Advanced Cutaneous Squamous Cell Carcinoma · Nasopharyngeal Cancinoma (NPC) · Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
GenesisCare North Shore, Sydney, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Contact: Study coordinator (Pei Ding)Contact: Principal Investigator (Pei Dr Ding)ICON Cancer Centre South Brisbane, Brisbane, Queensland, Australia
Greenslopes Private Hospital, Greenslopes, Queensland, Australia
Contact: Study coordinator (Rahul Ladwa)Contact: Principal Investigator (Rahul Ladwa)Southern Oncology Clinical Research Unit, Adelaide, South Australia, Australia
Contact: Study coordinator (Ganessan Kichenadasse)Contact: Principal Investigator (Ganessan Kichenadasse)Peninsula & South Eastern Haematology and Oncology Group, Frankston, Victoria, Australia
Contact: Study coordinator (Vinod Ganju)Contact: Principal Investigator (Vinod Prof Ganju)Cabrini Health, Malvern, Victoria, Australia
Linear Clinical Research, Perth, Western Australia, Australia
Contact: Study coordinator (Samantha Bowyer)Contact: Principal Investigator (Samantha Bowyer)The Institute of Oncology, ARENSIA Exploratory Medicine Phase I Unit, Chisinau, Moldova
Contact: Study coordinator (Iurie Bulat)Contact: Principal Investigator (Iurie Bulat)National Cancer Centre Singapore, Singapore, Singapore
Contact: Study coordinator (Aaron Tan)Contact: Principal Investigator (Aaron Tan)Tan Tock Seng Hospital, Singapore, Singapore
Contact: Study coordinator (Jens Samol)Contact: Principal Investigator (Jens Samol)Chungbuk National University Hospital, Cheongju-si, South Korea
Contact: Study coordinator (Ki Hyeong Lee)Contact: Principal Investigator (Ki Hyeong Lee)CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea
Contact: Study coordinator (Joo-Hang Kim)Contact: Principal Investigator (Joo-Hang Kim)Korea University Anam Hospital, Seoul, South Korea
Contact: Study coordinator (Yoon Ji Choi)Contact: Principal Investigator (Yoon Ji Choi)Severance Hospital, Seoul, South Korea
Contact: Study coordinator (Hye Ryun Kim)Contact: Principal Investigator (Hye Ryun Kim)The Catholic University of Korea St. Vincent's Hospital, Suwon, South Korea
Contact: Study coordinator (Byoung Yong Shim)Contact: Principal Investigator (Byoung Yong Shim)Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Contact: Study coordinator (Jen-Yu Hung)Contact: Principal Investigator (Jen-Yu Hung)National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Study coordinator (Chun-Hui Lee)Contact: Principal Investigator (Chun-Hui Lee)Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan
Contact: Study coordinator (Wei-Hong Cheng)Contact: Principal Investigator (Wei-Hong Cheng)Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Study coordinator (Yuh-Min Chen)Contact: Principal Investigator (Yuh-Min Chen)